CRISPRとCAS遺伝子の市場規模、シェア、成長分析、製品別、サービス別、用途別、エンドユーザー別、地域別 - 産業予測、2025～2032年

CRISPRとCAS遺伝子市場規模は2023年に35億米ドルと評価され、2024年の47億8,000万米ドルから2032年には583億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは36.70%で成長する見通しです。

CRISPRとCAS遺伝子市場は、多様な分野における遺伝子編集ツールや治療法に対する需要の高まりに後押しされ、近年目覚ましい成長と進化を遂げています。当社の包括的なレポートには広範なバリューチェーン分析が含まれており、メーカーはこの拡大する市場で競争上の優位性を確保することができます。主な促進要因としては、ヘルスケア、農業、産業バイオテクノロジーにおける応用範囲を広げる技術進歩が挙げられます。CRISPR（Clustered Regularly Interspaced Short Palindromic Repeats）およびCas（CRISPR-associated）技術は、遺伝子工学に革命をもたらし、DNA改変の精度を高めています。遺伝子疾患の急増、進行中の調査、共同研究は、倫理的・規制的課題にもかかわらず、成長をさらに加速させています。技術が進歩し、遺伝子機能の理解が深まるにつれて、CRISPRとCAS市場は複数の産業に変革をもたらすと思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

CRISPRとCAS遺伝子市場規模：製品別

• 市場概要
• キットと試薬
  • Casタンパク質と酵素
  • ガイドRNA
  • その他
• ライブラリ
• デザインツール
• 抗体
• その他

CRISPRとCAS遺伝子市場規模：サービス別

• 市場概要
• 細胞株エンジニアリング
• GRNAの設計と合成
• スクリーニングサービス
• その他

CRISPRとCAS遺伝子市場規模：用途別

• 市場概要
• バイオメディカル
  • ゲノム工学
  • 疾患モデル研究
  • 機能ゲノミクス
  • エピジェネティクス
  • その他
• 農業

CRISPRとCAS遺伝子市場規模：エンドユーザー別

• 市場概要
• バイオテクノロジーおよび製薬会社
• 学術機関および政府調査機関
• 契約調査機関（CROS）
• その他

CRISPRとCAS遺伝子市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• CRISPR Therapeutics（Switzerland）
• Beam Therapeutics（USA）
• Intellia Therapeutics（USA）
• Editas Medicine（USA）
• Caribou Biosciences（USA）
• Verve Therapeutics（USA）
• Prime Medicine（USA）
• Sangamo Therapeutics（USA）
• Wave Life Sciences（Singapore）
• Metagenomi（USA）
• Mammoth Biosciences（USA）
• Synthego Corporation（USA）
• EGenesis（USA）
• Inscripta（USA）
• Cellectis（France）
• OriGene Technologies（USA）
• Precision BioSciences（USA）
• Recombinetics（USA）

結論と推奨事項

CRISPR and CAS Gene Market size was valued at USD 3.5 Billion in 2023 and is poised to grow from USD 4.78 Billion in 2024 to USD 58.33 Billion by 2032, growing at a CAGR of 36.70% during the forecast period (2025-2032).

The CRISPR and CAS gene market has undergone remarkable growth and evolution recently, fueled by rising demand for gene-editing tools and therapies across diverse sectors. Our comprehensive report includes an extensive value chain analysis, empowering manufacturers to secure a competitive advantage in this expanding market. Key drivers include technological advancements that broaden application scopes in healthcare, agriculture, and industrial biotechnology. The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR-associated) technologies have revolutionized genetic engineering, offering precision in DNA modification. The surge in genetic disorders, ongoing research, and collaboration further accelerate growth, despite ethical and regulatory challenges. As technology progresses and understanding of gene functions deepens, the CRISPR and CAS market is set to transform multiple industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the CRISPR and CAS Gene market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

CRISPR and CAS Gene Market Segmental Analysis

Global CRISPR and CAS Gene Market is segmented by product, service, application, end user and region. Based on product, the market is segmented into kits & reagents, libraries, design tool, antibodies and others. Based on service, the market is segmented into cell line engineering, GRNA design & synthesis, screening services and others. Based on application, the market is segmented into biomedical and agricultural. Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, contract research organizations (CROS) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the CRISPR and CAS Gene Market

The CRISPR and CAS Gene market is significantly driven by the rising prevalence of genetic disorders, which include various conditions stemming from mutations or changes in specific genes. As the understanding of these genetic conditions deepens, there is a growing demand for advanced and precise gene-editing technologies like Crispr and Cas. These innovative tools offer tremendous potential for creating targeted therapies and personalized treatment approaches for patients with genetic disorders. The increasing global incidence of genetic diseases, combined with the urgent need for effective treatment solutions, fuels the demand for Crispr and Cas technologies, thus accelerating market expansion.

Restraints in the CRISPR and CAS Gene Market

The CRISPR and CAS Gene market faces several restraints primarily stemming from regulatory and ethical challenges associated with gene editing technologies. While the transformative power of Crispr offers immense possibilities, it simultaneously raises significant concerns regarding its responsible and ethical application. Discussions around the implications of germline editing, potential off-target effects, and unforeseen consequences fuel ongoing debates within the scientific community and beyond. Moreover, the lack of uniform regulatory frameworks across various countries and regions creates inconsistencies that may hinder market growth and restrict the adoption of these innovative gene-editing solutions, thereby impacting their overall potential in various applications.

Market Trends of the CRISPR and CAS Gene Market

The CRISPR and Cas gene market is witnessing significant growth, particularly in the agricultural sector, driven by the increasing adoption of gene editing technologies to enhance crop traits and resilience. Farmers and breeders are leveraging CRISPR for precise modifications, enabling the development of genetically modified organisms (GMOs) that exhibit superior yield, disease resistance, and adaptive traits like drought tolerance. This trend is heavily influenced by the urgent need for sustainable agricultural practices, heightened by global food security challenges and a rising population. As stakeholders seek innovative solutions, the CRISPR market is poised for expansion, fostering advancements in crop productivity and sustainable farming practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global CRISPR and CAS Gene Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits & Reagents
  • Cas Proteins & Enzymes
  • Guide RNA
  • Others
• Libraries
• Design Tool
• Antibodies
• Others

Global CRISPR and CAS Gene Market Size by Service & CAGR (2025-2032)

• Market Overview
• Cell Line Engineering
• GRNA Design & Synthesis
• Screening Services
• Others

Global CRISPR and CAS Gene Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomedical
  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others
• Agricultural

Global CRISPR and CAS Gene Market Size by End User & CAGR (2025-2032)

• Market Overview
• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations (CROS)
• Others

Global CRISPR and CAS Gene Market Size & CAGR (2025-2032)

• North America (Product, Service, Application, End User)
  • US
  • Canada
• Europe (Product, Service, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Service, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Service, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Service, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CRISPR Therapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verve Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prime Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wave Life Sciences (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metagenomi (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EGenesis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inscripta (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision BioSciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recombinetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations